HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arg⁹⁷² insulin receptor substrate-1 inhibits endothelial nitric oxide synthase expression in human endothelial cells by upregulating microRNA-155.

Abstract
The dysregulation of nitric oxide (NO) synthesis attributable to the abnormal expression/activity of endothelial NO synthase (eNOS) is considered to be a major characteristic of insulin-resistant states, as well as an essential contributor to the pathogenesis of cardiovascular diseases. The Arg972 insulin receptor substrate-1 (IRS-1) is associated with insulin resistance. In the present study, we investigated the association between Arg972 IRS-1 and eNOS expression/activity in human subjects and in primary cultures of human endothelial cells. Data from 832 human subjects revealed that heterozygous and homozygous Arg972 IRS-1 carriers had significantly lower levels of plasma eNOS and nitrite/nitrate than the homozygous wild-type (WT) IRS-1 carriers. Human umbilical vein endothelial cells (HUVECs) established from delivering mothers expressing heterozygous Arg972 IRS-1 had significantly lower eNOS expression/activity and higher miR-155 levels than those expressing WT homozygous IRS-1. The overexpression of IRS-1 and Arg972 IRS-1 in the HUVECs, respectively, decreased and increased the miR-155 expression level. In addition, the overexpression of IRS-1 in the HUVECs significantly increased eNOS expression; this effect was reversed by transfection with mature miR-155 mimic or treatment with the selective phosphatidylinositol-3 kinase (PI3K) inhibitor, BKM120. On the other hand, the overexpression of Arg972 IRS-1 markedly decreased eNOS expression and this effect was reversed by transfection with antagomir-155. On the whole, our in vivo data demonstrate that Arg972 IRS-1 is associated with decreased plasma eNOS and nitrite/nitrate levels in human subjects. Our in vitro data demonstrate that Arg972 IRS-1 inhibits eNOS expression in human endothelial cells by upregulating miR-155 expression through the impairment of PI3K signaling. The present study provides new insight into the pathophysiological role of Arg972 IRS-1 in cardiovascular diseases.
AuthorsCheng Huang, Guang Li, Haojian Dong, Shuo Sun, Haimin Chen, Demou Luo, Ling Sun, Xida Li, Zhujun Chen, Huijian Yang, Shuisheng Wei, Yingling Zhou
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 36 Issue 1 Pg. 239-48 (Jul 2015) ISSN: 1791-244X [Electronic] Greece
PMID25902041 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminopyridines
  • Insulin Receptor Substrate Proteins
  • MIRN155 microRNA, human
  • MicroRNAs
  • Morpholines
  • NVP-BKM120
  • Phosphoinositide-3 Kinase Inhibitors
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
Topics
  • Adult
  • Aged
  • Aminopyridines (pharmacology)
  • Cells, Cultured
  • Diabetes Mellitus (genetics)
  • Enzyme Activation (genetics)
  • Female
  • Human Umbilical Vein Endothelial Cells (metabolism)
  • Humans
  • Insulin Receptor Substrate Proteins (biosynthesis, genetics)
  • Insulin Resistance (genetics)
  • Male
  • MicroRNAs (biosynthesis, genetics)
  • Middle Aged
  • Morpholines (pharmacology)
  • Nitric Oxide (biosynthesis)
  • Nitric Oxide Synthase Type III (biosynthesis)
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: